JNGLX Janus Henderson Global Life Sciences D Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), AstraZeneca PLC (NASDAQ:AZN), Merck & Co (NYSE:MRK), Abbott Laboratories (NYSE:ABT).

The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

The average market capitalization across the Janus Henderson Global Life Sciences D MF is 302.55B. The market cap for tickers in the group ranges from 61.38M to 910.93B. LLY holds the highest valuation in this group at 910.93B. The lowest valued company is SANP at 61.38M.

The average weekly volume growth across all stocks in the Janus Henderson Global Life Sciences D MF was 13%. For the same stocks of the MF, the average monthly volume growth was 63% and the average quarterly volume growth was -51%